Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.

Eur Heart J · 2022 · PMC9492270 · PMID 35788657

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

40 Notably, the finding of a significant trend for treatment effect on reduced mortality in the highest SUA tertial does not suggest an increased mortality risk for patients with low SUA.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.